Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

Immunogenetics

Volumn 62, Issue 11-12, 2010, Pages 721-727

  Molderings, Gerhard J ^a   Meis, Kirsten ^b   Kolck, Ulrich W ^b   Homann, Jürgen ^b   Frieling, Thomas ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Evangelische Kliniken Bonn   (Germany)

^c HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

C Kit; Mast cell; Systemic mast cell activation syndrome; Systemic mastocytosis

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MAST CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC MASTOCYTOSIS;

ADULT; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; YOUNG ADULT;

EID: 78649326867     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-010-0474-8     Document Type: Article

References (36)

1. K Alfter I von Kügelgen B Haenisch, et al. 2009 New aspects of liver abnormalities as part of the systemic mast cell activation syndrome Liver Int. 29 181 186 10.1111/j.1478-3231.2008.01839.x 18662284 1:CAS:528: DC%2BD1MXisV2rtLk%3D
2. I Alvarez-Twose D González de Olano L Sánchez-Muñoz, et al. 2010 Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms J. Allergy Clin. Immunol. 125 1269 1278 10.1016/j.jaci.2010.02.019 20434205 1:CAS:528:DC%2BC3cXmslekurY%3D
3. SR Bandi C Brandts M Rensinghoff, et al. 2009 E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and a myeloproliferative disease Blood 114 4197 4208 10.1182/blood-2008-12-190934 19734451 1:CAS:528: DC%2BD1MXhsVGku7jO
4. C Bodemer O Hermine F Palmérini, et al. 2010 Pediatric mastocytosis is a clonal disease associated with D(816)V and other activating c-KIT mutations J. Invest. Dermatol. 130 804 815 10.1038/jid.2009.281 19865100 1:CAS:528:DC%2BC3cXhslSks7s%3D
5. M Castells KF Austen 2002 Mastocytosis: mediator related signs and symptoms Int. Arch. Allergy Immunol. 127 147 152 10.1159/000048188 11919427 1:CAS:528:DC%2BD38XitlGmtrk%3D (Pubitemid 34264205)
6. SC Chu JL Tang CC Li 2006 Dasatinib in chronic myelogenous leukemia N Engl J. Med. 355 1062 1063 10.1056/NEJMc061882 16960978 1:CAS:528: DC%2BD28XpsFKls7o%3D
7. A Duensing F Medeiros B McConarty, et al. 2004 Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs) Oncogene 23 3999 4006 10.1038/sj.onc.1207525 15007386 1:CAS:528: DC%2BD2cXjvVKgu78%3D (Pubitemid 38747928)
8. A Fontalba PJ Real JL Fernandez-Luna X Agirre F Prosper C Richard 2006 Identification of c-Kit gene mutations in patients with polycythemia vera Leuk. Res. 30 1325 1326 10.1016/j.leukres.2005.12.020 16460801 1:CAS:528: DC%2BD28XotlKitrk%3D
9. R Foster E Byrnes C Meldrum, et al. 2008 Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT Br. J. Dermatol. 159 1160 1169 18795925 1:STN:280:DC%2BD1cjmslenuw%3D%3D
10. R Fritsche-Polanz JH Jordan A Feix WR Sperr 2001 Mutation analysis of c-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis Br. J. Haematol. 113 357 364 10.1046/j.1365-2141.2001. 02783.x 11380399 1:CAS:528:DC%2BD3MXkvVOht7k%3D (Pubitemid 32523138)
11. SJ Galli J Kalesnikoff MA Grimbaldeston AM Piliponsky CM Williams M Tsai 2005 Mast cells as "tunable" effector and immunoregulatory cells: recent advances Annu. Rev. Immunol. 23 749 786 10.1146/annurev.immunol.21. 120601.141025 15771585 1:CAS:528:DC%2BD2MXktFOju70%3D (Pubitemid 40563184)
12. A Goncalves G Monges Y Yang 2006 Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis J. Natl Cancer Inst. 98 562 563 10.1093/jnci/djj137 16622127 (Pubitemid 43898822)
13. J Gotlib NCR Cross DG Gilliland 2006 Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy Best Pract. Res. Clin. Haematol. 19 535 569 10.1016/j.beha.2005.07.013 16781488 1:CAS:528: DC%2BD28Xls1aqurk%3D (Pubitemid 43869477)
14. MC Heinrich CL Corless GD Demetri, et al. 2003 Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J. Clin. Oncol. 21 4342 4349 10.1200/JCO.2003.04.190 14645423 1:CAS:528: DC%2BD2cXpsVWqu7Y%3D (Pubitemid 46621810)
15. MC Heinrich CL Corless CD Blanke, et al. 2006 Molecular correlates of imatinib resistance in gastrointestinal stromal tumors J. Clin. Oncol. 24 4764 4774 10.1200/JCO.2006.06.2265 16954519 1:CAS:528:DC%2BD28XhtFynsrrN (Pubitemid 46630941)
16. O Hermine O Lortholary PS Leventhal, et al. 2008 Case-control cohort study of patients' perceptions of disability in mastocytosis PLoS ONE 3 e2266 10.1371/journal.pone.0002266 18509466 1:CAS:528:DC%2BD1cXnsVOgtLg%3D
17. K Inokuchi H Yamaguchi M Tarusawa, et al. 2002 Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia-potential clinical significance Leukemia 16 170 177 10.1038/sj.leu.2402341 11840282 1:CAS:528:DC%2BD38XhvFGjtbY%3D
18. TM Kohl S Schnittger JW Ellwart W Hiddemann K Spiekermann 2005 KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor Blood 105 3319 3321 10.1182/blood-2004-06-2068 15618474 1:CAS:528: DC%2BD2MXjtlSlsrY%3D
19. Kolck UW (2009) Investigations on the pathogenesis of the systemic mast cell activation syndrome and its impact on heart function. Bonn, University, medical thesis; URN:nbn:de:hbz:5N-19064; http://hss.ulb.uni-bonn.de/2009/1906/ 1906.htm [in German]
20. J Lennartsson O Voytyuk E Heiss C Sundberg J Sun L Ronnstrand 2005 c-Kit signal transduction and involvement in cancer Cancer Ther. 3 5 28
21. S Lev Y Yarden D Givol 1992 A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses J. Biol. Chem. 267 10866 10873 1375232 1:CAS:528:DyaK38Xkt1Witr0%3D
22. KH Lim A Tefferi TL Lasho, et al. 2009 Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors Blood 113 5727 5736 10.1182/blood-2009-02-205237 19363219 1:CAS:528:DC%2BD1MXnsVSksL8%3D
23. M Mayerhofer KV Gleixner A Hoelbl, et al. 2008 Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens J. Immunol. 180 5466 5476 18390729 1:CAS:528:DC%2BD1cXkt1artrg%3D
24. GJ Molderings U Kolck C Scheurlen, et al. 2006 Systemic mast cell disease with gastrointestinal symptoms-a diagnostic questionnaire Dtsch Med. Wochenschr. 131 2095 2100 10.1055/s-2006-951337 16981082 1:STN:280: DC%2BD28rltlKnsQ%3D%3D [in German with English abstract] (Pubitemid 44544026)
25. GJ Molderings UW Kolck C Scheurlen M Brüss J Homann I von Kügelgen 2007 Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder Scand. J. Gastroenterol. 42 1045 1053 10.1080/00365520701245744 17710669 1:CAS:528:DC%2BD2sXpt1KisLY%3D (Pubitemid 47301141)
26. H Nagata AS Worobec DD Metcalfe 1996 Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects Exp. Clin. Immunogenet. 13 210 214 9165275 1:CAS:528:DyaK2sXjslWhs7w%3D
27. A Orfao AC Garcia-Montero L Sanchez L Escribano REMA 2007 Recent advances in the understanding of mastocytosis: the role of KIT mutations Br. J. Haematol. 138 12 30 10.1111/j.1365-2141.2007.06619.x 17555444 1:CAS:528:DC%2BD2sXos12hurc%3D (Pubitemid 46889785)
28. O Ozer YD Zhao KR Ostler, et al. 2008 The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells Leuk. Lymphoma 49 1567 1577 10.1080/10428190802140865 18766971 1:CAS:528:DC%2BD1cXhtVOitLvE
29. J Rocha M Luz Duarte H Marques, et al. 2010 Association of adult mastocytosis with M541L in the transmembrane domain of KIT J Eur Acad Dermatol Venereol 24 9 1118 1119 20236206 1:CAS:528:DC%2BC3cXhtFers7rO
30. S Tayal E Classen L Bemis WA Robinson 2005 C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis Anticancer Res. 25 2215 2220 16158966 1:CAS:528: DC%2BD2MXmtl2hu7o%3D
31. C Teodosio AC García-Montero M Jara-Acevedo, et al. 2010 Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes J. Allergy Clin. Immunol. 125 719 726 10.1016/j.jaci.2009.10.020 20061010 1:CAS:528:DC%2BC3cXjtFOqtbY%3D
32. P Valent HP Horny L Escribano, et al. 2001 Diagnostic criteria and classification of mastocytosis: a consensus proposal Leuk. Res. 25 603 625 10.1016/S0145-2126(01)00038-8 11377686 1:STN:280:DC%2BD3M3pslylsg%3D%3D (Pubitemid 32506768)
33. P Valent C Akin L Escribano, et al. 2007 Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria Eur J Clin Invest 37 435 453 10.1111/j.1365-2362.2007. 01807.x 17537151 1:STN:280:DC%2BD2szisFClsg%3D%3D (Pubitemid 46817344)
34. J Vendôme S Letard F Martin, et al. 2005 Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases J. Med. Chem. 48 6194 6201 10.1021/jm050231m 16190746 1:CAS:528:DC%2BD2MXpslWrsbw%3D (Pubitemid 41428974)
35. Yang Y, Létard S, Borge L (2010) Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 116:114-1123
36. S Yuzawa Y Opatowsky Z Zhang V Mandiyan I Lax J Schlessinger 2007 Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor Cell 130 323 334 10.1016/j.cell.2007.05.055 17662946 1:CAS:528:DC%2BD2sXovFalt7k%3D (Pubitemid 47081138)